ESC 365 - Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions

ESC Premium Access

Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions

Session: Novel drugs for cardiovascular diseases

Topic: Cardiovascular Pharmacotherapy

Speaker: Doctor U. Tigoer (Saratoga Springs, US)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Uwe Tigoer

Saratoga Springs (United States of America)

1 follower

5 more presentations in this session

Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial

Speaker: Doctor A. Morrow (Glasgow, GB)

Inhibition of ceramide de novo synthesis mitigates atherosclerosis

Speaker: Miss S. Chong (Singapore, SG)

Experimental evidence on colchicine's mode of action in human carotid artery plaques

Speaker: Mrs I. Steenbuck (Freiburg, DE)

The short-term prognosis of salvianolate use during hospitalization in patients with acute myocardial infarction

Speaker: Doctor R. Guo (Tianjin, CN)

SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study

Speaker: Mr C. Lv (Shanghai, CN)

Access the full session

Novel drugs for cardiovascular diseases

Speakers: Doctor U. Tigoer, Doctor A. Morrow, Miss S. Chong, Mrs I. Steenbuck, Doctor R. Guo...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources